VNDA logo

Vanda Pharmaceuticals (VNDA) Non Current Assets

Annual Non Current Assets

$215.49 M
+$100.54 M+87.46%

31 December 2023

VNDA Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Non Current Assets

$212.73 M
+$537.00 K+0.25%

30 September 2024

VNDA Quarterly Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

VNDA Non Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+87.5%+102.5%
3 y3 years+73.3%+80.3%
5 y5 years+553.0%+9.4%

VNDA Non Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+87.5%-1.3%+102.5%
5 y5 yearsat high+553.0%-1.3%+102.5%
alltimeall time-97.4%>+9999.0%-1.3%>+9999.0%

Vanda Pharmaceuticals Non Current Assets History

DateAnnualQuarterly
Sept 2024
-
$212.73 M(+0.3%)
June 2024
-
$212.19 M(-0.5%)
Mar 2024
-
$213.26 M(-1.0%)
Dec 2023
$432.95 M(-16.6%)
$215.49 M(+105.2%)
Sept 2023
-
$105.03 M(-2.9%)
June 2023
-
$108.18 M(-2.4%)
Mar 2023
-
$110.83 M(-3.6%)
Dec 2022
$519.29 M(+8.6%)
$114.95 M(+0.2%)
Sept 2022
-
$114.68 M(+2.2%)
June 2022
-
$112.21 M(+0.8%)
Mar 2022
-
$111.29 M(-3.6%)
Dec 2021
$478.30 M(+16.9%)
$115.49 M(-2.1%)
Sept 2021
-
$117.96 M(-2.5%)
June 2021
-
$120.99 M(-0.8%)
Mar 2021
-
$121.97 M(-1.9%)
Dec 2020
$409.14 M(+15.5%)
$124.31 M(-1.6%)
Sept 2020
-
$126.37 M(+0.5%)
June 2020
-
$125.77 M(-1.6%)
Mar 2020
-
$127.78 M(-1.4%)
Dec 2019
$354.14 M(+18.4%)
$129.61 M(-33.3%)
Sept 2019
-
$194.44 M(+243.0%)
June 2019
-
$56.68 M(+26.9%)
Mar 2019
-
$44.67 M(+35.4%)
Dec 2018
$299.13 M(+76.1%)
$33.00 M(-0.4%)
Sept 2018
-
$33.13 M(-2.1%)
June 2018
-
$33.82 M(-3.0%)
Mar 2018
-
$34.88 M(-1.9%)
Dec 2017
$169.86 M(-2.5%)
$35.57 M(-1.2%)
Sept 2017
-
$35.99 M(-0.2%)
June 2017
-
$36.06 M(-0.3%)
Mar 2017
-
$36.16 M(-0.1%)
Dec 2016
$174.18 M(+4.6%)
$36.20 M(-4.8%)
Sept 2016
-
$38.03 M(-8.7%)
June 2016
-
$41.66 M(-5.9%)
Mar 2016
-
$44.29 M(-4.8%)
Dec 2015
$166.55 M(+17.5%)
$46.50 M(-0.4%)
Sept 2015
-
$46.67 M(-5.4%)
June 2015
-
$49.32 M(-4.2%)
Mar 2015
-
$51.47 M(+71.7%)
Dec 2014
$141.73 M(+4.5%)
$29.97 M(+109.1%)
Sept 2014
-
$14.34 M(-4.1%)
June 2014
-
$14.95 M(-3.3%)
Mar 2014
-
$15.46 M(+99.9%)
DateAnnualQuarterly
Dec 2013
$135.61 M(+7.7%)
$7.74 M(-3.6%)
Sept 2013
-
$8.02 M(-6.7%)
June 2013
-
$8.60 M(-4.7%)
Mar 2013
-
$9.03 M(-4.8%)
Dec 2012
$125.97 M(-17.9%)
$9.48 M(-4.8%)
Sept 2012
-
$9.96 M(-8.2%)
June 2012
-
$10.85 M(-3.6%)
Mar 2012
-
$11.25 M(-61.4%)
Dec 2011
$153.50 M(-23.5%)
$29.12 M(-6.1%)
Sept 2011
-
$31.02 M(+160.4%)
June 2011
-
$11.91 M(-1.4%)
Mar 2011
-
$12.08 M(-3.6%)
Dec 2010
$200.57 M(-5.8%)
$12.53 M(+10.4%)
Sept 2010
-
$11.34 M(-3.9%)
June 2010
-
$11.80 M(-3.7%)
Mar 2010
-
$12.26 M(-4.0%)
Dec 2009
$212.95 M(+346.0%)
$12.76 M(-3.6%)
Sept 2009
-
$13.24 M(-3.5%)
June 2009
-
$13.72 M(+564.2%)
Mar 2009
-
$2.07 M(-5.6%)
Dec 2008
$47.75 M(-45.1%)
$2.19 M(-11.3%)
Sept 2008
-
$2.47 M(-52.2%)
June 2008
-
$5.16 M(-36.9%)
Mar 2008
-
$8.18 M(-17.5%)
Dec 2007
$86.96 M(+157.1%)
$9.91 M(+64.6%)
Sept 2007
-
$6.02 M(+156.0%)
June 2007
-
$2.35 M(-56.5%)
Mar 2007
-
$5.41 M(+121.7%)
Dec 2006
$33.82 M(+1.3%)
$2.44 M(-0.8%)
Sept 2006
-
$2.46 M(-2.1%)
June 2006
-
$2.51 M(-3.4%)
Mar 2006
-
$2.60 M(+9.1%)
Dec 2005
$33.37 M(+102.9%)
$2.38 M
Dec 2004
$16.45 M(-98.6%)
-
Dec 2003
$1.14 B(+28.8%)
-
Dec 2002
$884.75 M(+24.7%)
-
Dec 2001
$709.70 M(+46.3%)
-
Dec 2000
$485.15 M(+98.4%)
-
Dec 1999
$244.50 M(+12.4%)
-
Dec 1998
$217.50 M(-42.8%)
-
Dec 1997
$380.10 M(+255.9%)
-
Dec 1996
$106.80 M(+218.8%)
-
Dec 1995
$33.50 M(-5.4%)
-
Dec 1994
$35.40 M
-

FAQ

  • What is Vanda Pharmaceuticals annual long term assets?
  • What is the all time high annual non current assets for Vanda Pharmaceuticals?
  • What is Vanda Pharmaceuticals annual non current assets year-on-year change?
  • What is Vanda Pharmaceuticals quarterly long term assets?
  • What is the all time high quarterly non current assets for Vanda Pharmaceuticals?
  • What is Vanda Pharmaceuticals quarterly non current assets year-on-year change?

What is Vanda Pharmaceuticals annual long term assets?

The current annual non current assets of VNDA is $215.49 M

What is the all time high annual non current assets for Vanda Pharmaceuticals?

Vanda Pharmaceuticals all-time high annual long term assets is $8.38 B

What is Vanda Pharmaceuticals annual non current assets year-on-year change?

Over the past year, VNDA annual long term assets has changed by +$100.54 M (+87.46%)

What is Vanda Pharmaceuticals quarterly long term assets?

The current quarterly non current assets of VNDA is $212.73 M

What is the all time high quarterly non current assets for Vanda Pharmaceuticals?

Vanda Pharmaceuticals all-time high quarterly long term assets is $215.49 M

What is Vanda Pharmaceuticals quarterly non current assets year-on-year change?

Over the past year, VNDA quarterly long term assets has changed by +$107.69 M (+102.53%)